In its 3rd edition, the 3rd Edition of International Alzheimer's Disease, Dementia & Cognitive Disorders Conference (ADDC 2027) settles at NH Villa Carpegna in Rome from June 24-26, 2027, alongside a virtual channel that opens the meeting to attendees anywhere in the world. Organised by Magnus Group LLC, the Dementia Conference 2027 brings clinicians, neuroscientists, geriatricians, cognitive-disorder specialists, policy advocates, academic researchers, and pharmaceutical innovators into three days of scholarly programme, clinical exchange, and interdisciplinary conversation across Alzheimer's disease, dementia, and cognitive-disorder research.
Programme content covers diagnosis and early signs of disease, biomarkers for Alzheimer's and dementia, treatment strategies, cognitive decline and impairment, psychogeriatrics, depression and psychotic symptoms, geriatrics and healthy ageing, immunotherapy and stem-cell approaches, genetics in Alzheimer's and dementia, social and behavioural investigations, the relationship between inflammation and neurodegeneration, and current updates in Alzheimer's and dementia - designed to bring diagnostic, therapeutic, and policy perspectives into a single, coherent conversation.
Clinicians, researchers, and geriatric-medicine specialists are warmly invited to contribute original findings, clinical case work, and topical reviews for oral or poster presentation. Delegates and listeners may complete registration on the International Alzheimer's Conference 2027 portal, joining either on-site at NH Villa Carpegna or remotely from any country - both routes are equally supported by the hybrid format.
Reach us at:
E-mail: [email protected]
Phone: +1 (702) 988-2320
WhatsApp: +1 (540) 709-1879
Website: https://alzheimers.magnusconferences.com/